Suppr超能文献

通过反相高效液相色谱法分析尿中咖啡因代谢物以评估生物转化酶活性。

Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography.

作者信息

Krul C, Hageman G

机构信息

Department of Health Risk Analysis and Toxicology, Universiteit Maastricht, The Netherlands.

出版信息

J Chromatogr B Biomed Sci Appl. 1998 May 8;709(1):27-34. doi: 10.1016/s0378-4347(98)00016-4.

Abstract

An isocratic high-performance liquid chromatography procedure was developed for the analysis of five urinary metabolites of caffeine; caffeine or 1,3,7-trimethylxanthine (137X), paraxanthine or 1,7-dimethylxanthine (17X), 1,7-dimethylurate (17U), 1-methylxanthine (1X), 1-methylurate (1U) and 5-acetylamino-6-formylamino-3-methyluracil (AFMU). A standardized procedure was used for oral intake of caffeine and for urine collection. Conditions for sample storage and preparation were optimized, resulting in no detectable loss of caffeine metabolites after storage of the urine samples for four months. Urine samples were extracted with chloroform-2-propanol (4:1, v/v) and separated on a reversed-phase column with acetic acid (33%)-tetrahydrofuran-acetonitrile-water (1:2.5:44:925.5, v/v) as the eluent. Peaks were monitored at 280 nm. Peak heights were measured and the five metabolites were quantified using calibration curves. Cytochrome P4501A2 (CYP1A2) activity was calculated from the molar ratio (AFMU+1X+1U)/17U, N-acetyltransferase (NAT) from the ratio AFMU/1X, XO from the ratio 1U/1X+1U and cytochrome P4502A6 (CYP2A6) from the ratio 17U/(17U+17X+1U+ 1X+AFMU). The inter-assay coefficients of variation ranged from 1.7% for 17U to 5.7% for IX. The intra-individual variation in metabolite ratios determined in two people, with intervals of a few days to several weeks between measurements, ranged from 2. 1% for XO to 11.0% for CYP2A6. Using this procedure, metabolic ratios were determined for four groups of subjects; healthy, non-smoking females using oral contraceptives (OC users, n=5) and non-users (n=5), healthy nonsmoking males (n=9) and children (n=7). Results found in this study were comparable to results reported in the literature for subjects with similar characteristics. A significantly higher CYP1A2 ratio was found for males (4.87+/-0.47) compared to females (3.62+/-0.91: p=0.005, Mann-Whitney). For the other enzyme activities, no significant differences were found between the groups of subjects in this study.

摘要

开发了一种等度高效液相色谱法,用于分析咖啡因的五种尿代谢物;咖啡因或1,3,7 - 三甲基黄嘌呤(137X)、副黄嘌呤或1,7 - 二甲基黄嘌呤(17X)、1,7 - 二甲基尿酸(17U)、1 - 甲基黄嘌呤(1X)、1 - 甲基尿酸(1U)和5 - 乙酰氨基 - 6 - 甲酰氨基 - 3 - 甲基尿嘧啶(AFMU)。采用标准化程序进行咖啡因的口服摄入和尿液收集。优化了样品储存和制备条件,尿液样品储存四个月后,咖啡因代谢物未检测到损失。尿液样品用氯仿 - 2 - 丙醇(4:1,v/v)萃取,并在反相柱上分离,以乙酸(33%) - 四氢呋喃 - 乙腈 - 水(1:2.5:44:925.5,v/v)作为洗脱剂。在280 nm处监测峰。测量峰高,并使用校准曲线对五种代谢物进行定量。细胞色素P4501A2(CYP1A2)活性通过摩尔比(AFMU + 1X + 1U)/17U计算,N - 乙酰转移酶(NAT)通过AFMU/1X的比值计算,黄嘌呤氧化酶(XO)通过1U/1X + 1U的比值计算,细胞色素P4502A6(CYP2A6)通过17U/(17U + 17X + 1U + 1X + AFMU)的比值计算。批间变异系数范围为17U的1.7%至1X的5.7%。在两个人中测定的代谢物比值的个体内变异,测量间隔为几天至几周,范围从XO的2.1%至CYP2A6的11.0%。使用该程序,测定了四组受试者的代谢比值;健康、不吸烟且使用口服避孕药的女性(口服避孕药使用者,n = 5)和非使用者(n = 5)、健康不吸烟男性(n = 9)和儿童(n = 7)。本研究中发现的结果与文献中报道的具有相似特征的受试者的结果相当。发现男性的CYP1A2比值(4.87±0.47)显著高于女性(3.62±0.91:p = 0.005,曼 - 惠特尼检验)。对于其他酶活性,本研究中受试者组之间未发现显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验